Rapport Therapeutics launches $150 million convertible senior notes offering

Bitget2026/10/27 20:57

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Rapport Therapeutics launched a proposed $150 million public offering of convertible senior notes due 2032.
A 30-day underwriters’ option for $22.5 million in additional notes would bring the total to $172.5 million if fully exercised.
The general unsecured notes mature December 1, 2032; interest will be payable semiannually.
The interest rate and initial conversion rate will be determined at pricing.
Proceeds will support RAP-219 clinical trials, other research and development, and general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapport Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610271632PRIMZONEFULLFEED9854508) on October 27, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Rapport Therapeutics launches $150 million convertible senior notes offering

You may also like

Crypto prices